KRISTEN BATSON: Open Payments
NPI 1437550829 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,508 in 160 payments from 24 companies in 2025. Trend: 2023 $2,302 · 2024 $2,850 · 2025 $3,508
Food & beverage: $3,508
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 34 | $986 |
| ABBVIE INC. | 27 | $517 |
| SK Life Science, Inc. | 11 | $320 |
| PFIZER INC. | 20 | $315 |
| Neurelis, Inc. | 8 | $148 |
| Lilly USA, LLC | 7 | $121 |
| ACADIA Pharmaceuticals Inc | 5 | $111 |
| Aucta Pharmaceuticals, Inc. | 10 | $109 |
| CATALYST PHARMACEUTICALS, INC. | 4 | $95 |
| Eisai Inc. | 5 | $95 |
Products named: Fintepla, NURTEC ODT, QULIPTA, Briviact, LEQEMBI, Nayzilam, UBRELVY, VALTOCO.
Industry payments across FL — which companies pay providers there.
